Pet Health Supplements: Certifications & Parameters for Oral Dissolvable Films

What Makes Oral Dissolvable Films Different?

Traditional pet supplements—powders, tablets, chewables—face three persistent challenges: difficulty in feeding (pets refuse or spit out), low absorption (affected by short pet intestines and high stomach acidity), and inconsistent dosage. Oral dissolvable films (ODFs) address these by melting in the pet's mouth within 10 seconds, allowing active ingredients to be absorbed directly through the oral mucosa into the bloodstream. According to Novohope's data, this route achieves an absorption rate of up to 95%, compared to approximately 35% for conventional products.

Key Certifications for Pet Health Supplements (ODF/ODT)

For buyers evaluating a pet health supplement supplier, compliance with international standards is non‑negotiable. Novohope's products have obtained the following certifications, verified by third‑party agencies:

Certification	Standard / Regulation	Issuing Body	Applicable Market
FDA Food Facility Registration	Section 305 of U.S. Public Health Security and Bioterrorism Preparedness and Response Act of 2002	U.S. FDA	US
Safety Data Sheet (SDS)	OSHA Hazard Communication Standard 29 CFR 1910.1200 (HCS)	Shenzhen Deesev Testing International Corporation	US
Certificate of Analysis (COA)	Customized full ingredient composition analysis test (client designated test item)	Shenzhen Deesev Testing International Corporation	Global
Test Report (FDA 21 CFR 175.300)	US FDA 21 CFR 175.300	Shenzhen Deesev Testing International Corporation	US
Trademark Registration Acceptance	Trademark Law of the People’s Republic of China	National Intellectual Property Administration	China

Technical Parameters of Novohope ODF/ODT Products

Novohope offers seven product series, each formulated with an oral fast‑dissolving matrix. The table below summarizes key specifications:

Model	Type	Form	Spec	Key Ingredients
COAT+	Coat & Skin Health	ODF	2.5 g (10 films)	DHA, Biotin, N‑Acetylglucosamine, Sodium Hyaluronate
EYES+	Eye Care & Tear Stain	ODF	2.1 g	Lutein, Zeaxanthin, Taurine, NAC
CALM+	Calming & Stress Relief	ODT	2.5 g (10 films)	α‑casozepine, L‑theanine, Pediococcus acidilactici
BONE+	Joint Care	ODT	2.1 g (10 tabs)	Glucosamine HCl, UC‑II, Hydrolyzed Collagen Peptides
HEART+	Cardiovascular	ODT	2.1 g (10 tabs)	Coenzyme Q10, Taurine, L‑Carnitine, Vitamin E
PROBIO	Digestive Care	ODT	2.5 g (10 tabs)	Bacillus coagulans, Postbiotic Akkermansia muciniphila
FIT+	Weight Management	ODT	10 tabs	Taurine, L‑Carnitine, Vitamin E

Step‑by‑Step Breakdown: Evaluating a Pet ODF Supplier

1. Verify regulatory compliance – Confirm FDA registration (US), SDS, COA, and any local trademarks. Request the actual certificates.
2. Assess technical parameters – Check dissolution time (target ≤10 seconds), absorption route (mucosal vs. digestive), and ingredient doses per unit.
3. Examine customization capability – Can the manufacturer offer OEM/ODM for private label? Novohope provides brand agency, OEM, ODM, and custom packaging design.
4. Review quality control – Look for 100% full inspection before delivery plus third‑party sampling testing (as Novohope does).
5. Evaluate capacity and lead time – Monthly capacity of 200,000,000 units, lead time 35–45 days, MOQ 3,000 units per SKU.

Use Cases Across Pet Health Scenarios

Novohope’s product series target common pet health concerns. For example, the EYES+ model (ODF) is specifically formulated to support overall vision health and proactively manage or reduce unsightly tear stains. The COAT+ model nourishes skin and promotes a shiny coat. In calming scenarios (fireworks, travel), CALM+ (ODT) provides α‑casozepine and L‑theanine to soothe anxiety. The products are designed for room‑temperature storage and simple self‑licking administration—no tools required.

Proof of Market Traction

At the International Pet Exhibition in Nuremberg, Germany (May 2026), Novohope showcased six products, received over 700 global customers, and reached more than 100 potential clients. This was followed by the opening of a new R&D and marketing center in Shekou, Shenzhen in June 2026. The company’s technical team originates from the Wahsheer Biotechnology Laboratory at the Chinese University of Hong Kong.